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The illusive promise of circumcision to prevent female-to-male 
HIV infection – not the way to go for South Africa
‘Circumcision reduces HIV infections 76% in South Africa, researchers 
find’, screamed the headline in the online Bloomberg news, taking 
its cue from the reported findings of a randomised, controlled 
intervention trial (RCT) conducted at Orange Farm, Gauteng. The 
findings were presented by French researcher Bertran Auvert et al. in 
July 2011 at an AIDS conference in Rome, showing that circumcision 
significantly reduced the risk of female-to-male transmission of 
HIV. ‘We are changing the social norm,’ Auvert gushed at a news 
conference. ‘It’s the first time in the world that we have a successful 
intervention in a community to reduce the sexual transmission of 
HIV between adults.’
University of the Witwatersrand researcher Francois Venter echoed 
the triumphant tone, telling the Bulletin of the WHO that ‘Male 
circumcision is the most powerful intervention we have at this point 
in time. One of [its] beauties is that it is a one-off operation which 
takes 15 - 20 minutes but then has a profound effect on the rest of a 
man’s life; whereas to promote condom use or microbicides, repeated 
long-term promotion is needed.’ The most powerful intervention? 
A lay listener might be forgiven for concluding that circumcision 
represents a silver bullet that renders conventional prevention 
strategies obsolete.
Indeed, Marwick Khumalo, a Member of Parliament in Swaziland, 
was quoted in the local press as saying: ‘All male children should 
be circumcised. To show my seriousness, I have taken all my sons 
for circumcision.’ The KwaZulu-Natal correctional services report 
a near-stampede by prison inmates across the province demanding 
to be circumcised, and the authorities are scurrying about to set 
up circumcision stations in the prisons from their limited HIV 
prevention resources, apparently oblivious to the absence of any 
evidence that circumcision prevents male-to-male HIV transmission.
The evidence
The Orange Farm study was one of three independent RCTs conducted 
in South Africa,1 Uganda2 and Kenya3 to determine whether 
circumcision reduced the risk of female-to-male transfer of HIV 
infection during penetrative heterosexual sex. The results showed that 
the intervention significantly reduced the incidence of HIV infection 
in the circumcised study group compared with the controls, by 60% in 
South Africa, 53% in Kenya and 51% in Uganda. In all three studies, 
the benefits of intervention observed on interim calculations were 
judged by the researchers to be sufficiently convincing to justify early 
termination of the RCTs on ethical grounds.
The published conclusion of the South African study is more 
circumspect, declaring simply that ‘Male circumcision provides a 
degree of protection against acquiring HIV infection, equivalent 
to what a vaccine of high efficacy would have achieved. Male 
circumcision may provide an important way of reducing the spread 
of HIV infection in sub-Saharan Africa.’ The comparison to a vaccine 
has been contested, but the constrained demeanour is probably closer 
to reality.
The extended claim that circumcision confers lifelong protection 
seems like a stretch, and cannot be inferred from this or the other 
RCTs, all of which were terminated at 24 months or less. And because 
the control group were also offered circumcision at the termination 
of the RCT, the opportunity to continue longer-term follow-up was 
forever extinguished.
The three RCTs sought to test what has long been suggested in 
many epidemiological studies, dating back to 1987, that enquired 
into circumcision as a risk factor for HIV-1 infection among men. 
The studies, though not always consistent, appeared to show that 
circumcision reduces the risk of HIV infection in men. They were 
conducted in a wide variety of populations and environments, and a 
large diversity of research conditions. In 2000, Weiss et al.4 published 
a systematic review and meta-analysis of such studies, and concluded 
that ‘Male circumcision is associated with a significantly reduced 
risk of HIV infection among men in sub-Saharan Africa, particularly 
those at high risk of HIV.’ However, the authors concede that meta-
analyses are vulnerable to bias because studies yielding statistically 
significant findings are more likely to be submitted and published 
than studies with negative results.
On the other hand, a much-cited Cochrane systematic review from 
the South African Medical Research Council (MRC) published three 
years later,5 while also finding ‘a strong epidemiological association 
between male circumcision and prevention of HIV, especially among 
high-risk groups’, nevertheless cautioned that there was ‘insufficient 
evidence to support an interventional effect of male circumcision 
on HIV acquisition in heterosexual men’ because ‘the observational 
studies are inherently limited by confounding which is unlikely to be 
fully adjusted for’.
That was before the three RCTs, publication of which has led to the 
current drive to inflict mass circumcision on southern African men. 
Circumcision intervention has now been embraced by the WHO, the 
Centers for Disease Control, other health-based organisations and 
some researchers. Even the MRC has since reversed its position, with 
lead researcher Siegfried declaring on 15 April 2009 that ‘Research 
on the effectiveness of male circumcision for preventing HIV in 
heterosexual men is conclusive. No further trials are required to 
establish that HIV infection rates are reduced in heterosexual men 
for at least the first two years after circumcision.’
However, the three RCTs have not been without detractors. In a 
scathing critique, Van Howe and Storms6 point out that ‘In the South 
African trial, men who reported at least one episode of unprotected 
sex accounted for 2 498 person-years and 46 HIV infections during 
the trial. Among the remaining men, who accounted for 2076 
person-years, 23 became infected although they either had no sexual 
contact or always used a condom … Similarly, in the Ugandan trial, 
men who consistently used condoms had the same rate of infection 
as those who never used condoms. Finally, in the first three months 
of the Kenyan trial, five men became HIV-positive who reported 
no sexual activity in the period before the seroconversion.’ They 
conclude from their recalculations and statistical reasoning that 
‘Conservatively for the three trials, 89 of the 205 infections (43.1%) 
were sexually transmitted. Without knowing which infections were 
sexually transmitted [and which were not], it is impossible to test 
the hypothesis of whether circumcision reduces the rate of sexually 
transmitted HIV.’ Such studies, it must be said, depend on subject 
self-reporting, and, sexuality being a very private matter, the subjects 
may sometimes be inclined to be less than candid.
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Protagonists have touted universal neonatal circumcision 
(proscribed in South Africa under current law) even though, as 
cogently argued by Sidler et al.,7 no credible evidence exists linking 
circumcision to future protection from HIV in adulthood. The scale 
of the projected implementation is staggering. Kelly Curran, Technical 
Director of the HIV/AIDS and Infectious Diseases Department 
affiliated with Johns Hopkins University,8 envisages a roll-out aimed 
at 80% coverage in 13 countries involving approximately 28 million 
(that’s right, 28 million) procedures over 5 years. In Zambia and 
Swaziland, a partnership has been launched to circumcise 642  000 
adolescent boys and men over 5 years, with the support of a start-up 
grant of $50 million from the Bill and Melinda Gates Foundation. 
It is curious and even worrisome that the campaign to circumcise 
African men seems to be driven by donor funding and researchers 
from the North.
Why rolling out circumcision is not the way to go for 
South Africa
For all the drum-beating promotion of universal circumcision 
prophylaxis in southern Africa, the big question remains: what man 
would want to accept circumcision and the associated risks, if he were 
made clearly to understand the need to continue to abstain, be faithful 
and/or condomise? What then would be the benefit? A UNAIDS 
statement of 19 March 2009 states categorically that ‘The male latex 
condom is the single most efficient, available technology to reduce the 
sexual transmission of HIV and other sexually transmitted infections.’ 
Circumcision, on the other hand, is more expensive, more invasive 
and less effective by itself. As Van Howe and Storms6 put it, ‘It is not 
hard to see that circumcision is either inadequate (otherwise there 
would be no need for the continued use of condoms) or redundant 
(as condoms provide nearly complete protection).’ Circumcision 
roll-out will divert scarce resources in money, human resources and 
infrastructure away from essential health services, in a system that 
is already severely under-provided. Francois Venter is cited by Chris 
Bateman9 as stating quite correctly that circumcision roll-out would 
require ‘“serious energy, money and resources” for an effective scale-
up of what he believed should be a stand-alone service’. In South 
Africa today, VCT, ART and PMTCT – all of them with a proven 
impact on prevention – should merit more priority than circumcision 
in resource allocation.
Several authors have pointed out as well that, without field testing, 
it is impossible to predict the applicability and repeatability of the 
RCT findings in real-world situations. That the RCTs were terminated 
early does not help. Nor does South Africa’s experience with the HIV 
epidemic offer any clues. It is true that the Eastern Cape (EC)’s 
Xhosa speakers, who traditionally circumcise, have relatively lower 
prevalence rates (11%) than KwaZulu-Natal’s Zulu speakers (16%), 
who do not. The difference is not huge, and the EC rates are still 
way too high by any standard. On the other hand, the Western Cape, 
with a spotty circumcision tradition, has the lowest prevalence (6%) 
in the country, almost half that of the EC (ASSA2003 Projections for 
2010). According to one nationwide demographic survey,10 12.3% of 
circumcised men were HIV-positive, and 12.0% of intact men were 
similarly HIV-positive. Van Howe and Storms6 observe that among 
developed nations, the USA has the highest rate of (largely neonatal) 
circumcision and the highest rate of heterosexually transmitted 
HIV. Within the USA, black Americans have the highest rate of 
circumcision and the highest rate of heterosexually transmitted HIV. 
These data certainly show no distinct pattern relative to circumcision 
and the risk of HIV infection.
There is a real risk that the roll-out of circumcision will dilute 
the standard prevention messages and undermine the gains already 
made in respect of condom use and behaviour modification. This 
could result from risk compensation – a false sense of security. Risk 
compensation occurs when people engage in risky behaviour in 
the mistaken belief that they have acquired assured protection. For 
example, in their modelling exercise, Blower and McClean11 found 
that if an HIV vaccine offered 50% protection, but reduced condom 
use or increased other risky behaviours, it would be likely to result 
in higher HIV infection rates. The enthusiasm for circumcision 
among traditionally non-circumcising populations suggests that 
circumcision is perceived as special and sufficient protection, and 
there is a risk that medically circumcised men may feel ‘liberated’ to 
engage in risky behaviour, putting themselves and their partners in 
danger of infection. There is already some evidence to this effect. In 
the survey by Bridges et al.12 assessing determinants of demand for 
circumcision, South African men listed ‘It means that men don’t have 
[to] use a condom’ as an advantage of circumcision. It is noteworthy 
that circumcision does not protect women from infection risk, but 
may well increase that risk in the event of risk compensation by their 
partner.
South Africa must take a page from the book of the Australian 
Federation of AIDS Organisations13 which, in rejecting circumcision 
for Australia, reiterated that ‘correct and consistent condom use, not 
circumcision, is the most effective means of reducing female-to-male 
transmission, and vice-versa. 
Circumcision does not prevent 
HIV – in high prevalence 
areas it reduces the risk of 
female-to-male transmission. 
HIV acquisition rates were 
nevertheless high in both the 
circumcised and the non-
circumcised groups involved in 
the trials.’
Daniel J Ncayiyana
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